FDA OKs QVAR RediHaler for Asthma in Children Aged 4+ FDA OKs QVAR RediHaler for Asthma in Children Aged 4+

Teva ' s breath-actuated inhaler for the maintenance treatment of asthma will be available in early 2018 and will replace the older QVAR metered-dose inhaler.FDA Approvals

Source: Medscape Medical News Headlines - August 11, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Alert Source Type: news